Clinical Trials Logo

Myopic Progression clinical trials

View clinical trials related to Myopic Progression.

Filter by:
  • None
  • Page 1

NCT ID: NCT05192824 Recruiting - Myopic Progression Clinical Trials

Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

Start date: December 10, 2021
Phase: N/A
Study type: Interventional

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

NCT ID: NCT04295707 Active, not recruiting - Myopic Progression Clinical Trials

Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers

MR1
Start date: March 11, 2020
Phase: N/A
Study type: Interventional

The two-year prospective study aims at investigating the benefits of frequent replacement (monthly) orthokeratology lenses in myopia control in terms of effectiveness in control and prevention of ocular complications. The secondary objective will be investigating the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.

NCT ID: NCT04293328 Active, not recruiting - Myopic Progression Clinical Trials

Monthly Replacement Orthokeratology for Myopia Control in Young Children

MR2
Start date: July 7, 2020
Phase: N/A
Study type: Interventional

The two-year prospective study aims at investigating frequently replacement effect on myopia control in young children, and the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.

NCT ID: NCT02643875 Completed - Myopic Progression Clinical Trials

Investigation of the Effect of Short-term Orthokeratology With Increased Compression Factor on Ocular Parameters

Start date: February 26, 2016
Phase: N/A
Study type: Interventional

Orthokeratology (ortho-k) is a clinical technique that uses reverse geometry rigid gas permeable contact lens exerting positive pressure on the central cornea to temporary reduce refractive error. Researchers have shown that this treatment is effective for myopia control in low to high myopes, with and without astigmatism. Most designs of ortho-k lenses in the market are fitted based on the Jessen formula. The compression factor was introduced to compensate for the regression of the ortho-k effect during the no lens-wear period, so that the wearer can obtain clear distance vision throughout the day and most lens designs use a compression factor of 0.50-0.75 D. However, in a retrospective study (mixed brands of ortho-k lenses), it showed that most patients did not achieve an over-correction of 0.75 D. In order to achieve an over-correction of 0.75 D, an extra flattening power of about 1.50 D instead of 0.75 D should be be targeted. The increased compression factor is expected to increase the target reduction and it may play a role in myopic control and providing a higher successful rate in fitting ortho-k lenses.

NCT ID: NCT02643342 Completed - Myopic Progression Clinical Trials

A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye

Start date: June 18, 2016
Phase: N/A
Study type: Interventional

This is a two-year longitudinal study investigating the optical and structural effects of increased compression factor of orthokeratology lens on eyes and the corresponding effect on change in choroidal thickness and therefore myopic control.